Category: Johnson & JohnsonSyndicate content

Jury deliberations begin in first trial over DePuy's Pinnacle hips

October 22, 2014 by MassDevice

A jury begins deliberations in the 1st trial over DePuy Orthopaedics' Pinnacle metal-on-metal hip implant.

Jury deliberations begin in first trial over DePuy's Pinnacle hips

JNJ/Synthes integration continues to bring hefty charges | The week in medtech M&A

October 22, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: JNJ continues to pay hefty integration charges on Synthes deal; Stryker: Mako sales not as strong as we hoped; ConvaTec owners appoint banks to explore sale: sources; BD buys Irish next-gen sequencing startup GenCell Biosystems; Valeant says may raise Allergan bid; beats on profit

JNJ continues to pay hefty integration charges on Synthes deal

October 16, 2014 by Brian Johnson

Covidien wins injunction against J&J unit's surgical shears

October 17, 2014 by Brad Perriello

A federal judge bars sales of Johnson & Johnson unit Ethicon Endo-Surgery's Harmonic Ace +7 surgical shears in a patent infringement lawsuit brought by Covidien.

Covidien wins injunction against J&J unit's surgical shears

JNJ continues to pay hefty integration charges on Synthes deal

October 16, 2014 by Brian Johnson

More than 2½ years after it spent $21.3 billion on Synthes, Johnson & Johnson continues to take hefty charges on integrating the orthopedics company into its DePuy franchise.

JNJ continues to pay hefty integration charges on Synthes deal

J&J sales top forecast, helped by hepatitis drug

October 14, 2014 by MassDevice

Johnson & Johnson's 2nd-quarter sales top forecasts, prompting the medical product giant to raise its full-year earnings guidance.

J&J sales top forecast, helped by hepatitis drug

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medical device, drug companies paid $3.5B to docs, hospitals in 2013

October 1, 2014 by MassDevice

Medical device and pharmaceutical companies paid out $3.5 billion to doctors and hospitals during the last 5 months of 2013, according to new data from the Centers for Medicare & Medicaid Services, including a $30 million spend by Medtronic.

Medical device, drug companies paid $3.5B to docs, hospitals in 2013

NEW YORK (Reuters) – U.S. doctors and teaching hospitals received $3.5 billion from medical device makers and pharmaceutical companies in the last 5 months of 2013, according to the most extensive data trove on such payments ever made public.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Diabetes: Patients hack glucose monitors | MassDevice.com On Call

September 29, 2014 by Brad Perriello

More and more patients are reportedly hacking into their glucose monitors to add functions like online data display and continuous glucose monitoring.

MassDevice.com On Call

MASSDEVICE ON CALL — More and more patients are hacking into their glucose monitors to add functionality, with medical device companies lagging behind as they work their own improvements through the FDA, according to the Wall Street Journal.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp